Famous Greek-Cypriot electronic engineer Chris Toumazou, has struck again creating an innovative product, which is characterized as the most advanced anti-aging serum ever created.

The new personalized treatment is suited to each person’s skin needs. Thanks to the technology of a new microchip, the creators of the system can analyze, via a computer, the person’s genetic material within just 30 minutes and find out how fast their body breaks down collagen (a vital protein that keeps the skin looking young) as well as determine the level of antioxidants in the body (which protect it against the damaging free radicals).

The above information allows the scientists to develop quickly an anti-ageing cream tailored to the person’s needs that can reduce effectively the appearance of wrinkles.
According to British Telegraph, clinical trials over 18 months have already suggested that the product, named Geneu, reduces fine lines and wrinkles by up to 30% within just 12 weeks.

Chris Toumazou
DNA Electronics Chairman and Chief Scientific Advisor to GENEU Chris Toumazou was awarded the European Inventor Award 2014 in the Research Category for his rapid USB-based DNA-testing device. His creation of a lab-on-a-chip technology, a system that can test for genetic disease and drug intolerances in patients in less than 30 minutes, is just one of over 50 patents that Toumazou holds for medical diagnostic instruments.
The newly-crowned top inventor and winner of the prestigious contest left school with no formal qualifications. After failing his 11-plus, Toumazou – one of five children of Greek Cypriot immigrants to the U.K. – left school in Cheltenham. Rather than pursue a career in the family’s catering business, he decided to study electrical studies at the local City and Guilds.He took a two-year ordinary diploma and this was followed by a degree in engineering at Oxford Polytechnic, now Oxford Brookes University, and then a PhD.

Within two years he was the youngest-ever appointed professor at Imperial in the late Eighties. His study in DNA chip technology was spurred with greater intensity after it was discovered that his son Marcus suffered from a genetic condition that was slowly destroying his kidneys. To improve health monitoring, Toumazou put pieces of DNA in microchips and in so doing found that he could make devices that would trigger signals when they came in contact with a particular DNA sample.

Using the patient’s saliva, a GP can tell if a somebody has a predisposition to a disease or can metabolise a medical drug.